Table 1 Participant demographics and clinical characteristics
Cases | Control | p-value | |||
|---|---|---|---|---|---|
Age, mean (SD) years | 66.8 | (15.0) | 67.9 | (12.9) | 0.83 |
Body mass index, mean (SD), kg/m2 | 26.3 | (2.4) | 25.4 | (4.1) | 0.06 |
HAQ-DI, mean (SD) | 0.54 | (0.4) | 0.1 | (0.2) | < 0.01 |
Disease duration, mean (SD) years | 22.0 | (14.1) | |||
Rheumatoid factor positive, n (%) | 12 | (86%) | |||
Anti-CCP positive, n (%) | 5 | (36%) | |||
X-ray erosions, n (%) | 8 | (57%) | |||
CRP, mg/L mean (SD) | 4.9 | (4.5) | |||
Medications | |||||
DMARD use, n (%) | 9 | (64%) | |||
NSAID use, n (%) | 5 | (36%) | |||
Biologic use, n (%) | 2 | (14%) | |||
Corticosteroid use, n (%) | 5 | (36%) | |||